Aryastha Life Sciences Appoints Elite Executive Team To Lead Center for Translational Science
Aryastha Life Sciences Appoints Elite Executive Team To Lead Center for Translational Science
Discovery on Target conference in Boston, MA
We are thrilled to announce that ππ«π²ππ¬ππ‘π ππ’ππ πππ’ππ§πππ¬ will be attending the Discovery on Target conference in Boston, MA on September 30!
Join us to explore how Aryastha is driving innovation in preclinical discovery and integrated drug development. Our team is eager to share our unique approach to accelerating therapeutic discoveries and forming strategic collaborations.
Letβs meet and discuss how we can help you advance your next breakthrough!
π
ππππ: September 30, 2024
π ππ¨ππππ’π¨π§: Discovery on Target, Boston, MA
π Follow us for updates or schedule a meeting with us at the event!
Fragment-Based Lead Discovery Conference (FBLB 2024)
Aryastha Life Sciences will be attending the π π«ππ π¦ππ§π-πππ¬ππ ππππ ππ’π¬ππ¨π―ππ«π² ππ¨π§πππ«ππ§ππ (π πππ ππππ) in Boston from September 22-25, 2024. This prestigious event brings together leading experts in fragment-based drug discovery, and we are eager to engage with the vibrant scientific community.
As a premier drug discovery service provider, we invite biotech companies to connect with us at the conference. Letβs discuss how our comprehensive drug discovery and development offerings can elevate the evaluation of your assets and accelerate your journey from discovery to development.
π
Event Details:
β’ Date: September 22-25, 2024
β’ Location: George Sherman Union, Boston University, Boston, MA
Aryastha Life Sciences CEO Participates in Key Genome Valley Meeting with Telangana Minister
ππ«π²ππ¬ππ‘π ππ’ππ πππ’ππ§πππ¬ πππ πππ«ππ’ππ’π©ππππ¬ π’π§ πππ² πππ§π¨π¦π πππ₯π₯ππ² πππππ’π§π π°π’ππ‘ πππ₯ππ§π ππ§π ππ’π§π’π¬πππ«.
Dr. Raghava Reddy Kethiri, CEO of Aryastha Life Sciences, recently joined key industry leaders from Genome Valley in an exclusive meeting with Honorable Minister Shri Sridhar Babu Duddilla Garu, Minister of Information Technology, Electronics, Communications, Industries and Commerce, and Legislative Affairs, Telangana, along with other distinguished dignitaries. The discussions focused on the growth of the life sciences and biotech sectors in Genome Valley, Hyderabad.
During the meeting, Dr. Reddy shared his insights on the future of the biotech business and how Aryastha Life Sciences is positioning itself to capitalize on the FDA Modernization Act 3.0 and the Bio-Secure Act. As an end-to-end solution provider in drug discovery and development, Aryastha, co-founded by scientists from Harvard Medical School and Europe, leverages cutting-edge technologies such as iPSC, humanized tumor organoids, AI-augmented molecular profiling, and predictive tools for precision cancer therapies.
